Munro Partners Acquires Shares of 19,735 Ryan Specialty Holdings Inc. $RYAN

Munro Partners acquired a new position in Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 19,735 shares of the company’s stock, valued at approximately $1,342,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. SVB Wealth LLC acquired a new stake in Ryan Specialty during the 1st quarter worth about $26,000. Golden State Wealth Management LLC grew its holdings in Ryan Specialty by 10,975.0% during the second quarter. Golden State Wealth Management LLC now owns 443 shares of the company’s stock worth $30,000 after acquiring an additional 439 shares during the period. Central Pacific Bank Trust Division purchased a new position in Ryan Specialty during the second quarter valued at approximately $31,000. WPG Advisers LLC acquired a new position in Ryan Specialty in the first quarter valued at approximately $32,000. Finally, MAI Capital Management boosted its position in Ryan Specialty by 65.3% in the 2nd quarter. MAI Capital Management now owns 476 shares of the company’s stock worth $32,000 after purchasing an additional 188 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Trading Up 0.1%

Shares of Ryan Specialty stock opened at $54.19 on Friday. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 2.72. Ryan Specialty Holdings Inc. has a twelve month low of $50.08 and a twelve month high of $77.16. The firm has a market capitalization of $14.30 billion, a PE ratio of 117.81, a P/E/G ratio of 1.52 and a beta of 0.62. The firm’s 50-day moving average price is $55.40 and its 200 day moving average price is $59.32.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings data on Thursday, October 30th. The company reported $0.47 EPS for the quarter, hitting the consensus estimate of $0.47. The company had revenue of $754.58 million during the quarter, compared to analyst estimates of $742.35 million. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.Ryan Specialty’s quarterly revenue was up 24.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.41 EPS. On average, sell-side analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Tuesday, November 11th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Monday, November 10th. Ryan Specialty’s dividend payout ratio is currently 104.35%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Cowen reaffirmed a “buy” rating on shares of Ryan Specialty in a report on Wednesday, November 26th. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Wolfe Research upgraded Ryan Specialty to a “strong-buy” rating in a research report on Tuesday, September 16th. BMO Capital Markets reduced their price target on Ryan Specialty from $70.00 to $66.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Finally, Barclays lowered their price target on Ryan Specialty from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Thursday, November 20th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $66.60.

Get Our Latest Research Report on Ryan Specialty

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.